Brief: Centogene Extends Strategic Partnership With Takeda To Continue Providing Access To Genetic Testing For Patients With Lysosomal Storage Disorders
March 19 (Reuters) - Centogene NV 39K.MU :
* CENTOGENE EXTENDS STRATEGIC PARTNERSHIP WITH TAKEDA TO
CONTINUE
PROVIDING ACCESS TO GENETIC TESTING FOR PATIENTS WITH LYSOSOMAL
STORAGE DISORDERS
* CENTOGENE NV - UNDER RENEWED AGREEMENT, CENTOGENE WILL
CONTINUE
TO PROVIDE TAKEDA WITH ACCESS TO DIAGNOSTIC TESTING FOR PATIENTS
AROUND WORLD
Source text for Eikon: ID:nGNX5FjhX0
Further company coverage: 39K.MU
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Crown LiquidationCo NV in liquidatie
See all newsBrief: Centogene Signs Strategic Transaction With Private Equity Group Charme Capital Partners
Brief: Centogene Announces Adoption Of All Resolutions Tabled At 2024 Annual General Meeting
Brief: Centogene NV Says Agreements With LIFERA Provides Funding In Aggregate Of About $20 Mln To Co
Brief: Centogene And Evotec Discover Promising New Molecule To Treat Gaucher Disease
Brief: Centogene Receives Nasdaq Non-Compliance Notice